1McNally M, Curtain J, O' Brien KK, et al. Validity of British Thorac- ic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: systematic review and meta-analysis [J]. Br J Gen Pract,2010,60(579) :423-433.
2Aliberti S, Amir A, Peyrani P, et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with com- munity-acquired pneumonia[J]. Chest,2008,134:955-962.
3Arancibia F, Ewig S, Martinez JA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia [ J ]. Am J Respir Crit Care Med ,2000,162 : 154-160.
4Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults[ J]. Clin Infect Dis ,2007,44 :S27-72.
5Halm EA, Fine M J, Marrie TJ, et al. Time to clinical stability in patients hospitalized with CAP [ J ]. JAMA, 1998,279 : 1452 - 1457.
6Roson B, Carratala J, Fernandez-Sabe N, et al. Causes and factors associated with early failure in hospitalized patients with community- acquired pneumonia[J]. Arch Intern Med,2004,164:502-508.
7E1-Solh AA, Aquilina AT, Dhillon RS, et al. Impact of invasive strategy on management of antimicrobial treatment failure in institu- tionalized older people with severe pneumonia[ J]. Am J Respir Crit Care Med ,2002,166:1038-1043.
8Moran GJ, Krishnadasan A, Gorwitz R J, et al. Prevalence of methi- cillin-resistant staphylococcus aureus as an etiology of community-ae- quiredpneumonia[ J ]. Clin Infect Dis ,2012,54 ( 8 ) : 1126-1133.
9Roson B, Carratala J, Fernandez-Sabe N, et al. Causes and factors associated with early failure in hospitalized patients with community- acquired pneumonia[ J]. Arch Intern Med,2004,164:502-508.
10Low DE, Maszulli T, Marrie T. Progressive and nonresolving pneu- monia[ J]. Curr OpinPulm Med,2005,11 (3) :247-252.
7Baudouin S V. The pulmonary physician in critical care. 3 : critical care management of community acquired pneumonia. Thorax. 2002,57(3) :267-271.
8Menegazzi J J, Seaberg D C, Yealy D M, et al. Combination pharmacotherapy with delayed countershock vs standard advanced cardiac life support after prolonged ventricular fibrillation. Prehosp Emerg Care. 2000,4(1) :31-37.
10Wan Q J, Hu HF, He YC, et al. Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy [ J ]. Kaohsiung J Med Sci, 2015, 31(1) :42-46.
